Emergent Biodefense Operations Lansing LLC Secures $235.8M Contract for BioThrax Anthrax Vaccines

Emergent Biodefense Operations Lansing LLC, Lansing, Michigan, was awarded a $235,800,000 firm-fixed-price contract for BioThrax anthrax vaccines. Bids were solicited via the internet with one received. Work locations and funding will be determined with each order, with an estimated completion date of Sept. 30, 2033. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W911SR-24-D-0001).